A rapid LC method for the determination of haloperidol and its degradation products in pharmaceuticals using a porous graphitic carbon column

Journal of Liquid Chromatography and Related Technologies

Volumn 26, Issue 2, 2003, Pages 261-271

  Monser, Lotfi ^a   Trabelsi, Hassen ^b  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b SIP Ibn Albaytar   (Tunisia)

Author keywords

Degradation products; Haloperidol; Isocratic elution; Porous graphitic carbon

Indexed keywords

DEGRADATION; LIQUID CHROMATOGRAPHY; POROUS MATERIALS;

DEGRADATION PRODUCTS;

ORGANIC COMPOUNDS;

4 [4 (4 CHLOROPHENYL) 3,6 DIHYDRO 1(2H) PIPERIDINYL] 1 (4 FLUOROPHENYL) 1 BUTANONE; 4 [4 (4 CHLOROPHENYL) 4 HYDROXY 1 PIPERIDINYL] 1 (4 FLUOROPHENYL) 1 BUTANONE N OXIDE; 4 [4 (4 CHLOROPHENYL) 4 HYDROXY 1 PIPERIDINYL] 1 (4 HYDROXYPHENYL) 1 BUTANONE; CARBON; DRUG METABOLITE; GRAPHITE; HALOPERIDOL; TETRAHYDROFURAN; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG STRUCTURE; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 0037276026     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120017167     Document Type: Article

References (17)

1. Beasley, C.; Tollefson, G.; Tran, P.; Satterlee, W.; Sanger, T.; Hamilton, S. Olizapine versus placebo and haloperidol double blind olizapine trial. Neuropsycho-Pharmacology 1996, 14, 111-123.
2. Driouich, R.; Trabelsi, H.; Bouzouita, K. Stability-indicating assay for haloperidol syrup by HPLC. Chromatographia 2001, 53, 629-634.
3. Trabelsi, H.; Raouafi, F.; Saddem, A.; Bouzouita, K. Separation and determination of haloperidol, methyl and propyl paraben by HPLC. J. Pharm. Belg. 1997, 52, 145-148.
4. Fang, J.; Gorrod, J. HPLC method for detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations. J. Chromatogr. 1993, 614, 267-272.
5. Lea, A.; Dailey, D.; Duguid, P. Analysis of haloperidol tablets by HPLC - an inter-laboratory study. J. Chromatogr. 1982, 250, 3542.
6. Tsuneyosh, T. High. Resolut. Chromatogr. Commun. 1986, 9, 254-259.
7. Raggi, M.; Casamenti, G.; Mandrioli, R.; Sabbioni, C.; Volterra V. A rapid LC method for the idendification and determination of CNS drugs in pharmaceuticals. J. Pharma. Biom. Anal. 2000, 23, 161-167.
8. Xu, X.; Stewart, J. HPLC analysis of haloperidol and its related compound in drug substance and tablet dosage form using non-porous silica octadecylsilane column. J. Liq. Chrom. & Rel. Technol. 1999, 22, 1857-1866.
9. Trabelsi, H.; Bouabdallah, S.; Bouzouita, K.; Safta, F. Determination and degradation study of haloperidol by HPLC. J. Pharma. Biom. Anal. 2002, 29, 649-657.
10. The United State Pharmacopeia, 23rd Ed.; National Formulary 18, Rockvilie, MD, 1995; 731-733.
11. Vial, J.; Hennion, M.; Fernandez-Alba, A.; Aguera, A. Use of porous graphite carbon coupled with mass detection for the analysis of polar phenolic compounds by liquid chromatography. J. Chromatogr. A 2001, 937, 21-39.
12. Lim, C. Porous graphitic carbon in biomedical applications. Adv. Chromatogr. 1992, 32, 1-19.
13. Mercier, J.; Morin, Ph.; Dreux, M.; Tambute, A. Liquid chromatographic analysis of phosphonic acids on porous graphitic carbon stationary phase with evaporative light scattering and mass spectrometry detection. J. Chromatogr. A 1999, 849, 197-207.
14. Karlsson, A.; Berglin, M.; Charron, C. Robustness of the chromatographic separation of alprenolol and related substances using silica based stationary phase and metoprelol on porous graphitic carbon. J. Chromatogr. A 1998, 797, 75-82.
15. Monser, L.; Darghouth, F. Rapid liquid chromatographic method for simultaneous determination of tetracycline antibiotics and 6-epi-doxycycline in pharmaceuticals using porous graphitic carbon. J. Pharm. Biomed. Anal. 2000, 23, 353-362.
16. Monser, L.; Darghouth, F. Simultaneous LC determination of paracetamol and related compounds in pharmaceuticals using porous graphitic carbon correspondence. J. Pharm. Biomed. Anal. 2002, 27, 851-860.
17. The United State Pharmacopeia, 24th Ed.; United States Pharmacopeial Convention Rockville, MD, 2000; 2150-2151.